These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 34781741)

  • 1. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
    Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
    mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
    de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
    Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
    Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL;
    J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4
    Jones BR; Miller RL; Kinloch NN; Tsai O; Rigsby H; Sudderuddin H; Shahid A; Ganase B; Brumme CJ; Harris M; Poon AFY; Brockman MA; Fromentin R; Chomont N; Joy JB; Brumme ZL
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART.
    Brooks K; Omondi FH; Liang RH; Sudderuddin H; Jones BR; Joy JB; Brumme CJ; Hunter E; Brumme ZL
    Front Microbiol; 2021; 12():719153. PubMed ID: 34489909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
    Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir.
    Patro SC; Niyongabo A; Maldarelli F; Kearney MF
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
    Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobamibias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL
    Res Sq; 2023 Aug; ():. PubMed ID: 37645749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
    Trémeaux P; Lemoine F; Mélard A; Gousset M; Boufassa F; Orr S; Monceaux V; Gascuel O; Lambotte O; Hocqueloux L; Saez-Cirion A; Rouzioux C; Avettand-Fenoel V
    Microbiol Spectr; 2023 Feb; 11(1):e0326722. PubMed ID: 36692300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy.
    Shahid A; Jones BR; Yang JSW; Dong W; Shaipanich T; Donohoe K; Brumme CJ; Joy JB; Leung JM; Brumme ZL
    PLoS Pathog; 2022 Nov; 18(11):e1010613. PubMed ID: 36331974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct viral reservoirs in individuals with spontaneous control of HIV-1.
    Jiang C; Lian X; Gao C; Sun X; Einkauf KB; Chevalier JM; Chen SMY; Hua S; Rhee B; Chang K; Blackmer JE; Osborn M; Peluso MJ; Hoh R; Somsouk M; Milush J; Bertagnolli LN; Sweet SE; Varriale JA; Burbelo PD; Chun TW; Laird GM; Serrao E; Engelman AN; Carrington M; Siliciano RF; Siliciano JM; Deeks SG; Walker BD; Lichterfeld M; Yu XG
    Nature; 2020 Sep; 585(7824):261-267. PubMed ID: 32848246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy.
    Miller RL; Ponte R; Jones BR; Kinloch NN; Omondi FH; Jenabian MA; Dupuy FP; Fromentin R; Brassard P; Mehraj V; Chomont N; Poon AFY; Joy JB; Brumme ZL; Routy JP;
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy.
    Gandhi RT; Cyktor JC; Bosch RJ; Mar H; Laird GM; Martin A; Collier AC; Riddler SA; Macatangay BJ; Rinaldo CR; Eron JJ; Siliciano JD; McMahon DK; Mellors JW;
    J Infect Dis; 2021 Feb; 223(2):225-233. PubMed ID: 32823274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing HIV-1 evolution and reservoir reseeding in two elite controllers with genetically diverse peripheral proviral quasispecies.
    de Azevedo SSD; Côrtes FH; Villela LM; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
    Mem Inst Oswaldo Cruz; 2023; 118():e230066. PubMed ID: 37283423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 continues to replicate and evolve in patients with natural control of HIV infection.
    Mens H; Kearney M; Wiegand A; Shao W; Schønning K; Gerstoft J; Obel N; Maldarelli F; Mellors JW; Benfield T; Coffin JM
    J Virol; 2010 Dec; 84(24):12971-81. PubMed ID: 20926564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses.
    Kinloch NN; Shahid A; Dong W; Kirkby D; Jones BR; Beelen CJ; MacMillan D; Lee GQ; Mota TM; Sudderuddin H; Barad E; Harris M; Brumme CJ; Jones RB; Brockman MA; Joy JB; Brumme ZL
    mBio; 2023 Dec; 14(6):e0241723. PubMed ID: 37971267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-molecule techniques to quantify and genetically characterise persistent HIV.
    Wang XQ; Palmer S
    Retrovirology; 2018 Jan; 15(1):3. PubMed ID: 29316955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative HIV-1 Proviral Dynamics in Two Individuals That Maintained Viral Replication Control with or without Antiretroviral Therapy following Superinfection.
    de Azevedo SSD; Côrtes FH; Villela LM; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.
    Woldemeskel BA; Kwaa AK; Blankson JN
    EBioMedicine; 2020 Dec; 62():103118. PubMed ID: 33181459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.
    Wang X; Xu H
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.